| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $235.1M | +34.0% |
| Cost of Revenue | $28.2M | +99.7% |
| R&D Expense | $20.8M | -58.1% |
| SG&A Expense | $172.0M | -11.8% |
| Operating Income | -$4.7M | +94.9% |
| Pre-tax Income | $7.4M | +109.6% |
| Income Tax | $1.7M | +207.8% |
| Net Income | $5.8M | +107.4% |
| EPS (Basic) | $0.04 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $83.4M | +71.1% |
| Accounts Receivable | $36.5M | +51.7% |
| Inventory | $39.2M | -1.2% |
| Current Assets | $446.6M | +5.1% |
| Total Assets | $550.6M | +0.5% |
| Current Liabilities | $97.8M | +26.7% |
| Total Liabilities | $173.2M | +1.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $44.4M | +232.7% |
| Investing Cash Flow | $39.3M | +685.5% |
| Financing Cash Flow | -$49.1M | -857.0% |
| +107.4% |
| EPS (Diluted) | $0.04 | +107.4% |
| Stockholders' Equity |
| $377.5M |
| -0.1% |